Insights

Minaris Regenerative Medicine’s leaders and experts are proud to share their knowledge and insight with the cell and gene therapy industry. Please review our current and past blog posts on topics of interest to this emerging industry.

*This page may include mention of our past company names as it reflects content distributed in the past. The former companies Hitachi Chemical Advanced Therapeutics Solutions (HCATS, formerly PCT or PCT Cell Therapy Services), apceth Biopharma GmBH are all now operations under the name Minaris Regenerative Medicine. Hitachi Chemical Co., Ltd. has been renamed Showa Denko Materials Co., Ltd.

November 15, 2016

Current and Future Scale-Out Needs in Cell Therapy Manufacturing

The following is an excerpt from a paper originally published online in the journal Cytotherapy on October 26, 2016, entitled, “Bioreactors for cell therapies: Current ...

October 28, 2016

Look Before You Leap – Planning Ahead in Cell Therapy Manufacturing

The following is an excerpt of an article I wrote that was originally published in the October 2016 issue of The Medicine Maker. Some companies still fail to look beyond ...

June 22, 2016

Cell Therapy Manufacturing Challenges and Solutions, Phase by Phase--Part 3

This is the third in a three-part series (read Part 1 and Part 2 for the complete picture). As you approach cell therapy commercialization—having traveled what is still ...

June 8, 2016

Cell Therapy Manufacturing Challenges and Solutions, Phase by Phase--Part 2

This is the second in a three-part series (Part 1 can be found here). As you enter this mid-phase of development, we reflect on these words from Albert Einstein: “In the ...

June 6, 2016

Managing the Challenges of Cell Therapy Product Delivery in Clinical and Commercial Settings

PCT was recently featured in the BioProcess International Industry Yearbook. The article by Sanjin Zvonic, Ph.D., Director of Technology and Business Development for ...

May 25, 2016

Cell Therapy Manufacturing Challenges and Solutions, Phase by Phase--Part 1

If you’re reading this, you’ve no doubt already discovered that cell therapy manufacturing comes with its share of specific challenges, no matter what phase of ...

February 26, 2016

Scalability in Cell-based Therapy Manufacture

The following content, written by Thomas Heathman, MEng, PhD, Business Development Associate, PCT, was originally published on the blog of the website Technology ...

November 3, 2015

Scoring the Goal—10 Questions to Ask your External Manufacturing Partner

If you’re a striker (playing forward position) on a soccer team, you know that your primary role is to score a goal. But what makes you confident in your ability to ...

October 20, 2015

Good Quality is Good Business—Finding your Unified Quality Voice

The following is an excerpt from an article originally published in the October issue of BioProcess International, written by:

Previous All Posts Next